Last updated on March 2019

Do you have Metastatic Colorectal Cancer?

Brief description of study

Phase 2 Study Comparing Efficacy and Safety of ABT-165 plus FOLFIRI vs Bevacizumab plus FOLFIRI in Metastatic Colorectal Cancer Previously Treated with Fluoropyrimidine/Oxaliplatin and Bevacizumab


Detailed Study Description

To estimate the PFS of ABT-165 plus irinotecan, fluorouracil and leucovorin chemotherapy regimen (FOLFIRI) compared to bevacizumab plus FOLFIRI, as assessed by blinded independent central review, in subjects with previously treated mCRC who have received a regimen containing fluoropyrimidine, oxaliplatin, and bevacizumab.


Clinical Study Identifier: TX155593

Contact Investigators or Research Sites near you

Start Over

IACT Health

Columbus, GA United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.